Samsung Biologics: Post-Offering Trading Dynamics on Potential Overhang
This post discusses Samsung Biologics' post-offering trading dynamics on potential overhang as a little more than 1M new shares, 22x ADTV, will...
443 Views
SK Shieldus IPO - The Negatives - No Shield for Its Margin, in Multi-Year Decline
SK Shieldus (SKS) aims to raise around US$800m via a mix of issuing primary and secondary shares in its Korea IPO. In this note, we talk about the...
473 Views
Micron Posts Another Excellent Quarter
Micron Technology posted solid results for its 2QF22 with a very positive outlook. The company has been performing superbly, and should do very...
244 Views
ECM Weekly (27th Mar 2022) - JD, Tencent, Prosus, Ferretti, Recbio, Nomura, Navi, Samsung, Celltrion
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
382 Views
JD.com Tencent Distribution - Updates on the Now US$15bn Overhang and the Prosus Angle
On 23rd Dec 2021, Tencent declared a special interim dividend in the form of a distribution in specie of 457.326m shares of JD.com. In this note we...
844 Views